Leading pharmaceutical and med tech companies choose Mtech Access to develop their market access and health economics and outcomes research (HEOR) strategy.
What we do:
Our ultimate goal at Mtech Access is to support our clients in ensuring that life-enhancing interventions are available to the patients who need them. We do this by overcoming reimbursement and regulatory barriers to access, supporting product launches and effectively communicating product value to healthcare decision makers. Our comprehensive range of evidence-based market access solutions are informed by industry and technical expertise paired with real-world insights.
This all supports our shared commitment to making clients’ projects successful and delivering optimal outcomes for patients. We pride ourselves on delivering work of the highest quality, exceeding expectations and working in a flexible pragmatic way in partnership with our clients.
Our services include:
- Health Economics Strategy and Modelling
- Systematic literature review and network meta-analysis
- Global market access and pricing strategy
- European market access strategy
- Local market access strategy
- UK NHS insights and education
- HTA strategy and submission support
- Local value communication
- Payer communication tools
- Localised budget impact models and value proposition toolkits
- eDetail solutions, data driven interactive visual aids and digital sales aids
- Veeva digital tools (We are a full service Veeva content partners)
Our team of inhouse market access consultants, health economists, writers, analysts and developers are experienced and skilled, and ready to help you with your latest market access challenge. We have access to a broad network of payers, clinicians and other stakeholders across global markets, who we regularly engage to inform our insights and recommendations.